Benson Hill’s world-class scientists discover new mechanism for CRISPR technology that detects RNA

ST. LOUIS, MO – Jan. 13, 2023 – A groundbreaking research study by a team that included scientists from Benson Hill, Inc. (NYSE: BHIL, the “Company” or “Benson Hill”), has been published this month in Nature, the world’s leading multidisciplinary journal, highlighting a new mechanism for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology. The research paper, titled “Cas12a2 elicits abortive infection via RNA-triggered destruction of dsDNA,” discusses the discovery of a new enzymatic capability for CRISPR systems, opening the possibility of using CRISPR in new applications beyond gene editing – including cancer therapeutics, programmable shaping of microbial communities, and counterselection to enhance gene editing.  READ MORE